| Year |
Citation |
Score |
| 2022 |
Read GH, Bailleul J, Vlashi E, Kesarwala AH. Metabolic response to radiation therapy in cancer. Molecular Carcinogenesis. 61: 200-224. PMID 34961986 DOI: 10.1002/mc.23379 |
0.341 |
|
| 2020 |
Bhat K, Saki M, Vlashi E, Cheng F, Duhachek-Muggy S, Alli C, Yu G, Medina P, He L, Damoiseaux R, Pellegrini M, Zemke NR, Nghiemphu PL, Cloughesy TF, Liau LM, et al. The dopamine receptor antagonist trifluoperazine prevents phenotype conversion and improves survival in mouse models of glioblastoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 32358191 DOI: 10.1073/Pnas.1920154117 |
0.408 |
|
| 2019 |
Duhachek-Muggy S, Bhat K, Medina P, Cheng F, He L, Alli C, Saki M, Sree Muthukrishnan SD, Ruffenach G, Eghbali M, Vlashi E, Pajonk F. Radiation Mitigation of the Intestinal Acute Radiation Injury in Mice by 1-[(4-Nitrophenyl)Sulfonyl]-4-Phenylpiperazine. Stem Cells Translational Medicine. PMID 31464098 DOI: 10.1002/Sctm.19-0136 |
0.396 |
|
| 2019 |
Zhang L, Bailleul J, Yazal T, Dong K, Sung D, Dao A, Gosa L, Nathanson D, Bhat K, Duhachek-Muggy S, Alli C, Dratver MB, Pajonk F, Vlashi E. PK-M2-mediated metabolic changes in breast cancer cells induced by ionizing radiation. Breast Cancer Research and Treatment. PMID 31372790 DOI: 10.1007/S10549-019-05376-9 |
0.452 |
|
| 2019 |
Jung SY, Malhotra P, Nguyen KC, Salzman D, Qi Y, Pak EH, King J, Vlashi E, Ann D, Weidhaas JB. The KRAS-variant and its impact on normal breast epithelial cell biology. Cell Death and Differentiation. PMID 30932013 DOI: 10.1038/S41418-019-0320-Y |
0.392 |
|
| 2019 |
Bhat K, Duhachek-Muggy S, Ramanathan R, Saki M, Alli C, Medina P, Damoiseaux R, Whitelegge J, McBride WH, Schaue D, Vlashi E, Pajonk F. 1-(4-nitrobenzenesulfonyl)-4-penylpiperazine increases the number of Peyer's patch-associated regenerating crypts in the small intestines after radiation injury. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 132: 8-15. PMID 30825974 DOI: 10.1016/J.Radonc.2018.11.011 |
0.34 |
|
| 2019 |
Bhat K, Sandler K, Duhachek-Muggy S, Alli C, Cheng F, Moatamed NA, Magyar CE, Du L, Li G, McCloskey S, Vlashi E, Pajonk F. Serum erythropoietin levels, breast cancer and breast cancer-initiating cells. Breast Cancer Research : Bcr. 21: 17. PMID 30700319 DOI: 10.1186/S13058-019-1100-9 |
0.428 |
|
| 2019 |
Bailleul J, Yazal T, Sung D, Palomera D, Sehgal A, Dao A, Vlashi E. Abstract C59: NRF2 drives metabolic reprogramming in irradiated pancreatic cancer cells and promotes radioresistance Cancer Research. 79. DOI: 10.1158/1538-7445.Panca19-C59 |
0.451 |
|
| 2019 |
Bailleul J, Yazal T, Sung D, Dao A, Palomera D, Sehgal A, Vlashi E. Irradiation Reprograms GBM Metabolism Towards an Antioxidant Profile That Drives Radiation Resistance International Journal of Radiation Oncology*Biology*Physics. 105: S165-S166. DOI: 10.1016/J.Ijrobp.2019.06.189 |
0.317 |
|
| 2018 |
Zhang L, Bochkur Dratver M, Yazal T, Dong K, Nguyen A, Yu G, Dao A, Bochkur Dratver M, Duhachek-Muggy S, Bhat K, Alli C, Pajonk F, Vlashi E. Mebendazole potentiates radiation therapy in triple-negative breast cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 30196056 DOI: 10.1016/J.Ijrobp.2018.08.046 |
0.453 |
|
| 2018 |
Yazal T, Dao A, Dong S, Dratver MB, Vlashi E. Metabolic Regulation of Cancer Cell Response to Radiation Therapy International Journal of Radiation Oncology Biology Physics. 102. DOI: 10.1016/J.Ijrobp.2018.07.696 |
0.418 |
|
| 2017 |
Duhachek-Muggy S, Bhat K, Vlashi E, Pajonk F. Growth Differentiation Factor 11 does not Mitigate the Lethal Effects of Total-Abdominal Irradiation. Radiation Research. PMID 28829672 DOI: 10.1667/Rr14628.1 |
0.387 |
|
| 2016 |
Zhang L, Xu L, Zhang F, Vlashi E. Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer. Cell Cycle (Georgetown, Tex.). 0. PMID 27753527 DOI: 10.1080/15384101.2016.1241929 |
0.445 |
|
| 2016 |
Vlashi E, Chen AM, Boyrie S, Yu G, Nguyen A, Brower PA, Hess CB, Pajonk F. Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status. International Journal of Radiation Oncology, Biology, Physics. 94: 1198-206. PMID 27026319 DOI: 10.1016/J.Ijrobp.2016.01.005 |
0.313 |
|
| 2016 |
Dratver MB, Siu RT, Boyer S, Nguyen A, Frohnen P, Pajonk F, Vlashi E. Abstract A07: Inhibiting radiation-induced reprogramming of breast cancer cells via metabolic perturbation Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Metca15-A07 |
0.492 |
|
| 2016 |
Vlashi E, Chen AM, Boyrie S, Yu G, Nguyen A, Brower PA, Hess CB, Pajonk F. Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells into Cancer Stem Cells Depends on Human Papillomavirus Status International Journal of Radiation Oncology Biology Physics. 94: 1198-1206. DOI: 10.1016/j.ijrobp.2016.01.005 |
0.345 |
|
| 2015 |
Vlashi E, Pajonk F. The metabolic state of cancer stem cells-a valid target for cancer therapy? Free Radical Biology & Medicine. 79: 264-8. PMID 25450330 DOI: 10.1016/J.Freeradbiomed.2014.10.732 |
0.433 |
|
| 2015 |
Vlashi E, Pajonk F. Cancer stem cells, cancer cell plasticity and radiation therapy. Seminars in Cancer Biology. 31: 28-35. PMID 25025713 DOI: 10.1016/J.Semcancer.2014.07.001 |
0.449 |
|
| 2014 |
Varghese B, Vlashi E, Xia W, Ayala Lopez W, Paulos CM, Reddy J, Xu LC, Low PS. Folate receptor-β in activated macrophages: ligand binding and receptor recycling kinetics. Molecular Pharmaceutics. 11: 3609-16. PMID 25166491 DOI: 10.1021/Mp500348E |
0.633 |
|
| 2014 |
Vlashi E, Lagadec C, Vergnes L, Reue K, Frohnen P, Chan M, Alhiyari Y, Dratver MB, Pajonk F. Metabolic differences in breast cancer stem cells and differentiated progeny. Breast Cancer Research and Treatment. 146: 525-34. PMID 25007966 DOI: 10.1007/S10549-014-3051-2 |
0.443 |
|
| 2014 |
Lagadec C, Vlashi E, Bhuta S, Lai C, Mischel P, Werner M, Henke M, Pajonk F. Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients. Bmc Cancer. 14: 152. PMID 24593279 DOI: 10.1186/1471-2407-14-152 |
0.435 |
|
| 2014 |
Lagadec C, Vlashi E, Frohnen P, Alhiyari Y, Chan M, Pajonk F. The RNA-binding protein Musashi-1 regulates proteasome subunit expression in breast cancer- and glioma-initiating cells. Stem Cells (Dayton, Ohio). 32: 135-44. PMID 24022895 DOI: 10.1002/Stem.1537 |
0.392 |
|
| 2013 |
Vlashi E, Kelderhouse LE, Sturgis JE, Low PS. Effect of folate-targeted nanoparticle size on their rates of penetration into solid tumors. Acs Nano. 7: 8573-82. PMID 24020507 DOI: 10.1021/Nn402644G |
0.501 |
|
| 2013 |
Vlashi E, Lagadec C, Chan M, Frohnen P, McDonald AJ, Pajonk F. Targeted elimination of breast cancer cells with low proteasome activity is sufficient for tumor regression. Breast Cancer Research and Treatment. 141: 197-203. PMID 24013708 DOI: 10.1007/S10549-013-2688-6 |
0.491 |
|
| 2013 |
Pajonk F, Vlashi E. Characterization of the stem cell niche and its importance in radiobiological response. Seminars in Radiation Oncology. 23: 237-41. PMID 24012337 DOI: 10.1016/J.Semradonc.2013.05.007 |
0.388 |
|
| 2013 |
Lagadec C, Vlashi E, Alhiyari Y, Phillips TM, Bochkur Dratver M, Pajonk F. Radiation-induced Notch signaling in breast cancer stem cells. International Journal of Radiation Oncology, Biology, Physics. 87: 609-18. PMID 23992604 DOI: 10.1016/J.Ijrobp.2013.06.2064 |
0.438 |
|
| 2013 |
Steinberg M, McBride WH, Vlashi E, Pajonk F. National Institutes of Health funding in radiation oncology: a snapshot. International Journal of Radiation Oncology, Biology, Physics. 86: 234-40. PMID 23523324 DOI: 10.1016/J.Ijrobp.2013.01.030 |
0.317 |
|
| 2012 |
Lagadec C, Vlashi E, Della Donna L, Dekmezian C, Pajonk F. Radiation-induced reprogramming of breast cancer cells. Stem Cells (Dayton, Ohio). 30: 833-44. PMID 22489015 DOI: 10.1002/Stem.1058 |
0.463 |
|
| 2012 |
Yang J, Vlashi E, Low P. Folate-linked drugs for the treatment of cancer and inflammatory diseases. Sub-Cellular Biochemistry. 56: 163-79. PMID 22116699 DOI: 10.1007/978-94-007-2199-9_9 |
0.533 |
|
| 2012 |
Lagadec CH, Vlashi E, Dekmezian C, Pajonk F. Abstract 416: Radiation-induced reprograming of breast cancer cells Cancer Research. 72: 416-416. DOI: 10.1158/1538-7445.Am2012-416 |
0.446 |
|
| 2011 |
Vlashi E, Lagadec C, Vergnes L, Matsutani T, Masui K, Poulou M, Popescu R, Della Donna L, Evers P, Dekmezian C, Reue K, Christofk H, Mischel PS, Pajonk F. Metabolic state of glioma stem cells and nontumorigenic cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 16062-7. PMID 21900605 DOI: 10.1073/Pnas.1106704108 |
0.411 |
|
| 2011 |
Lagadec CH, Donna LD, Vlashi E, Dekmezian C, Brocks T, Pajonk F. Abstract 4372: Radiation induces Notch-dependent de novo generation of breast cancer stem cells via expression of OCT-4/SOX2/NANOG Cancer Research. 71: 4372-4372. DOI: 10.1158/1538-7445.Am2011-4372 |
0.477 |
|
| 2011 |
Chann L, Vlashi E, Lorenza D, Dekmezian C, Pajonk F. P1-04-06: Ionizing Radiation Reprograms Non-Tumorigenic Cancer Cells into Cancer Stem Cells. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P1-04-06 |
0.451 |
|
| 2010 |
McDonald JT, Kim K, Norris AJ, Vlashi E, Phillips TM, Lagadec C, Della Donna L, Ratikan J, Szelag H, Hlatky L, McBride WH. Ionizing radiation activates the Nrf2 antioxidant response. Cancer Research. 70: 8886-95. PMID 20940400 DOI: 10.1158/0008-5472.Can-10-0171 |
0.41 |
|
| 2010 |
Vlashi E, Mattes M, Lagadec C, Donna LD, Phillips TM, Nikolay P, McBride WH, Pajonk F. Differential Effects of the Proteasome Inhibitor NPI-0052 against Glioma Cells. Translational Oncology. 3: 50-5. PMID 20165695 DOI: 10.1593/Tlo.09244 |
0.412 |
|
| 2010 |
Lagadec C, Vlashi E, Della Donna L, Meng Y, Dekmezian C, Kim K, Pajonk F. Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment. Breast Cancer Research : Bcr. 12: R13. PMID 20158881 DOI: 10.1186/Bcr2479 |
0.451 |
|
| 2010 |
Vlashi E, Pajonk F. Targeted cancer stem cell therapies start with proper identification of the target. Molecular Cancer Research : McR. 8: 291; author reply 29. PMID 20145040 DOI: 10.1158/1541-7786.Mcr-09-0505 |
0.414 |
|
| 2010 |
Pajonk F, Vlashi E, McBride WH. Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited. Stem Cells (Dayton, Ohio). 28: 639-48. PMID 20135685 DOI: 10.1002/Stem.318 |
0.453 |
|
| 2010 |
Lagadec CH, Vlashi E, Donna LD, Meng Y, Dekmezian C, Kim K, Pajonk F. Abstract 4287: Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment Cancer Research. 70: 4287-4287. DOI: 10.1158/1538-7445.Am10-4287 |
0.423 |
|
| 2010 |
Vlashi E, Evers P, Lee P, Selch M, DeMarco J, Agazaryan N, Sayre JW, Kim K, Frank P. Abstract 4276: In-vivo imaging of glioma cancer stem cells Cancer Research. 70: 4276-4276. DOI: 10.1158/1538-7445.Am10-4276 |
0.438 |
|
| 2010 |
Vlashi E, Lagadec C, Donna LD, Meng Y, Dekmezian C, Pajonk F. Abstract 4241: Glioma stem cells perform oxidative phosphorylation, while the rest of glioma cells perform aerobic glycolysis Cancer Research. 70: 4241-4241. DOI: 10.1158/1538-7445.Am10-4241 |
0.4 |
|
| 2010 |
Donna LD, Lagadec C, Vlashi E, Meng Y, Dekmezian C, Souda P, Whitelegge JP, Pajonk F. Abstract 1063: The activity of the 26S proteasome is modulated during the different phases of the cell cycle Cancer Research. 70: 1063-1063. DOI: 10.1158/1538-7445.Am10-1063 |
0.382 |
|
| 2010 |
Lagadec C, Donna LD, Vlashi E, Dekmezian C, Pajonk F. Abstract PD02-10: Radiation Induces Notch-DependentDe NovoGeneration of Breast Cancer Stem Cells Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-Pd02-10 |
0.46 |
|
| 2009 |
Vlashi E, Sturgis JE, Thomas M, Low PS. Real time, noninvasive imaging and quantitation of the accumulation of ligand-targeted drugs into receptor-expressing solid tumors. Molecular Pharmaceutics. 6: 1868-75. PMID 19754150 DOI: 10.1021/Mp900158D |
0.525 |
|
| 2009 |
Vlashi E, McBride WH, Pajonk F. Radiation responses of cancer stem cells. Journal of Cellular Biochemistry. 108: 339-42. PMID 19623582 DOI: 10.1002/Jcb.22275 |
0.493 |
|
| 2009 |
Vlashi E, Kim K, Lagadec C, Donna LD, McDonald JT, Eghbali M, Sayre JW, Stefani E, McBride W, Pajonk F. In vivo imaging, tracking, and targeting of cancer stem cells. Journal of the National Cancer Institute. 101: 350-9. PMID 19244169 DOI: 10.1093/Jnci/Djn509 |
0.488 |
|
| 2009 |
Lagadec C, Vlashi E, Donna LD, McBride W, Pajonk F. Low proteasome activity as a means to track and target breast cancer stem cells in-vivo. Cancer Research. 69: 5055. DOI: 10.1158/0008-5472.Sabcs-5055 |
0.479 |
|
| 2009 |
Lagadec C, Vlashi E, Donna LD, Pajonk F. The Response of Breast Cancer Initiating Cells to Fractionated Radiation. Cancer Research. 69: 1153-1153. DOI: 10.1158/0008-5472.Sabcs-09-1153 |
0.436 |
|
| 2008 |
Varghese B, Vlashi E, Low PS. Folate Receptor Saturation, Recycling, and Release Kinetics in Activated Macrophages Blood. 112: 4655-4655. DOI: 10.1182/Blood.V112.11.4655.4655 |
0.523 |
|
| 2008 |
Vlashi E, Kim K, Donna LD, McDonald T, Lagadec C, McBride WH, Frank P. Prospective identification, tracking, and targeting of cancer-initiating cells in breast cancer and glioma via low proteasome activity Cancer Research. 68: 4997-4997. DOI: 10.1158/1538-7445.Am2008-4997 |
0.401 |
|
| 2007 |
Phillips TM, Kim K, Vlashi E, McBride WH, Pajonk F. Effects of recombinant erythropoietin on breast cancer-initiating cells. Neoplasia (New York, N.Y.). 9: 1122-9. PMID 18084619 DOI: 10.1593/Neo.07694 |
0.431 |
|
| 2007 |
Acharya G, Chang CL, Doorneweerd DD, Vlashi E, Henne WA, Hartmann LC, Low PS, Savran CA. Immunomagnetic diffractometry for detection of diagnostic serum markers. Journal of the American Chemical Society. 129: 15824-9. PMID 18047330 DOI: 10.1021/Ja073094M |
0.453 |
|
| 2007 |
Low P, He W, Vlashi E, Cheng J, Kennedy M. Optical Imaging of Cancer Cells in vivo with Folate Receptor-Targeted Fluorescent Dyes Microscopy and Microanalysis. 13. DOI: 10.1017/S1431927607073928 |
0.472 |
|
| 2006 |
Paulos CM, Varghese B, Widmer WR, Breur GJ, Vlashi E, Low PS. Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis. Arthritis Research & Therapy. 8: R77. PMID 16646988 DOI: 10.1186/Ar1944 |
0.627 |
|
| Show low-probability matches. |